SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,606.75 482.92
( 0.66%)

Global Indices

Nasdaq

52,379.88 143.72
(0.28%)

Dow Jones

7,698.05 53.37
(0.70%)

Hang Seng

62,433.43 -259.73
(-0.41%)

Nikkei 225

10,766.40 76.04
(0.71%)

Forex

USD-INR

94.61 0.10
(0.11%)

EUR-INR

106.18 0.08
(0.07%)

GBP-INR

126.70 0.19
(0.15%)

JPY-INR

0.60 0.00
(0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Symbiotec Pharmalab consolidated net profit declines 53.01% in the June 2026 quarter

Sep 23,2026

Net profit of Symbiotec Pharmalab declined 53.01% to Rs 14.06 crore in the quarter ended June 2026 as against Rs 29.92 crore during the previous quarter ended June 2025. Sales rose 7.37% to Rs 218.15 crore in the quarter ended June 2026 as against Rs 203.17 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	218.15	203.17	7
OPM %	20.72	28.53	-
PBDT	39.36	55.33	-29
PBT	17.53	44.82	-61
NP	14.06	29.92	-53

73,606.75 482.92 ( 0.66%)

52,379.88 143.72 (0.28%)

7,698.05 53.37 (0.70%)

62,433.43 -259.73 (-0.41%)

10,766.40 76.04 (0.71%)

94.61 0.10 (0.11%)

106.18 0.08 (0.07%)

126.70 0.19 (0.15%)

0.60 0.00 (0.70%)